|
Volumn 34, Issue 12, 2016, Pages 1215-1217
|
Despite slow progress, bispecifics generate buzz
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISPECIFIC ANTIBODY;
CLINICAL TRIAL (TOPIC);
DRUG DEVELOPMENT;
ECONOMICS;
HUMAN;
MOLECULARLY TARGETED THERAPY;
ANTIBODIES, BISPECIFIC;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
HUMANS;
MOLECULAR TARGETED THERAPY;
|
EID: 85019289859
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1216-1215 Document Type: Article |
Times cited : (16)
|
References (0)
|